jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 16, 2013

Dec. 17, 2018

jRCT2080222144

Exploratory clinical trial of KIB-PCI in healthy Japanese children

version:
date:

DAIICHISANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/contact/clinical/index.html

30

Interventional

Single-center, uncontrolled, open-label study

2

1) healthy Japanese children

1) Subjects with history of H5N1 influenza
2) Subjects with history of H5N1 influenza vaccination

No limit
No limit

Both

Prophylaxis of new type of influenza infection

investigational material(s)
Generic name etc : KIB-PCI
INN of investigational material :
Therapeutic category code : 631 Vaccines
Dosage and Administration for Investigational material : intramuscular

SRH antibody titer

HI antibody titer
Neutralizing antibody titer

DAIICHISANKYO Co.,Ltd.
KITASATO DAIICHI SANKYO VACCINE COMPANY, LIMITED

JapicCTI-132190

History of Changes

No Publication date
9 Dec. 17, 2018 (this page) Changes
8 Nov. 02, 2016 Detail Changes
7 Nov. 01, 2016 Detail Changes
6 Jan. 27, 2014 Detail Changes
5 Jan. 27, 2014 Detail Changes
4 Oct. 21, 2013 Detail Changes
3 Oct. 21, 2013 Detail Changes
2 July. 16, 2013 Detail Changes
1 July. 16, 2013 Detail